Financial News
Purple Biotech Ltd ADR (NQ: PPBT )
2.540
+0.070
(+2.83%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
All News about Purple Biotech Ltd ADR
Purple Biotech Reaches Recommended Phase 2 Dose for NT219
February 01, 2024
From Purple Biotech Ltd.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 10, 2024
Via Benzinga
Purple Biotech Appoints Dr. Yael Margolin to its Board of Directors
December 20, 2023
From Purple Biotech Ltd.
Via GlobeNewswire
From Purple Biotech Ltd.
Via GlobeNewswire
Purple Biotech: Q3 Earnings Insights
November 21, 2023
Via Benzinga
Purple Biotech: Q1 Earnings Insights
May 16, 2023
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 11, 2023
Via Benzinga
Purple Biotech Fortifies NT219 Patent Protection
November 02, 2023
From Purple Biotech Ltd.
Via GlobeNewswire
From Purple Biotech Ltd.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 17, 2023
Via Benzinga
Purple Biotech Announces $5 Million Registered Direct Offering
October 17, 2023
From Purple Biotech Ltd.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
October 13, 2023
Via Benzinga
Purple Biotech Reports Second Quarter 2023 Financial Results
August 22, 2023
From Purple Biotech Ltd.
Via GlobeNewswire
Via Benzinga
Purple Biotech Debuts Scientific Advisory Board
April 25, 2023
From Purple Biotech Ltd.
Via GlobeNewswire
From Purple Biotech Ltd.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.